Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Putra Rajawali Kencana Tbk. (PURA) Price & Performance

UBC Medical Indonesia Tbk.Trade
Putra Rajawali Kencana Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Putra Rajawali Kencana Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume), while Putra Rajawali Kencana Tbk. trades at Rp33 (market cap 214.27B, 4.84M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 3.2× Putra Rajawali Kencana Tbk.'s market cap, and Putra Rajawali Kencana Tbk. is more actively traded (4.84M versus 635.5K). Which is the better fit depends on your goals.

LABSPURA
Market Cap
691.25B214.27B
Volume
635.5K4.84M
Lot
6.36K48.39K
Turnover
110.15M155.41M
Average Price
173.3332.12
Value
110.15M155.41M
Indicative Equilibrium Price
17433
Indicative Equilibrium Volume
502.7K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
PURA
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Putra Rajawali Kencana Tbk.

PT Putra Rajawali Kencana Tbk (the Company) was established based on notary deed No. 05 dated April 17, 2012 of Juanita Sari Dewi, SH., notary in Surabaya.

Read more on PURA